Werewolf Therapeutics (HOWL) Accumulated Depreciation & Amortization (2021 - 2025)
Werewolf Therapeutics (HOWL) has disclosed Accumulated Depreciation & Amortization for 5 consecutive years, with $6.6 million as the latest value for Q4 2025.
- Quarterly Accumulated Depreciation & Amortization rose 32.78% to $6.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.6 million through Dec 2025, up 32.78% year-over-year, with the annual reading at $6.6 million for FY2025, 32.78% up from the prior year.
- Accumulated Depreciation & Amortization for Q4 2025 was $6.6 million at Werewolf Therapeutics, up from $5.0 million in the prior quarter.
- The five-year high for Accumulated Depreciation & Amortization was $6.6 million in Q4 2025, with the low at $391000.0 in Q4 2021.
- Average Accumulated Depreciation & Amortization over 5 years is $2.6 million, with a median of $1.4 million recorded in 2022.
- The sharpest move saw Accumulated Depreciation & Amortization surged 259.59% in 2022, then soared 32.78% in 2025.
- Over 5 years, Accumulated Depreciation & Amortization stood at $391000.0 in 2021, then soared by 259.59% to $1.4 million in 2022, then surged by 125.46% to $3.2 million in 2023, then skyrocketed by 57.22% to $5.0 million in 2024, then skyrocketed by 32.78% to $6.6 million in 2025.
- According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $6.6 million, $5.0 million, and $3.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.